wow jili secret code today
Pep Guardiola’s side avoided the indignity of a sixth successive defeat in all competitions and looked on course for a welcome victory thanks to a double from Erling Haaland – the first from the penalty spot – and a deflected effort from Ilkay Gundogan. Yet Guardiola was left with his head in hands as Feyenoord roared back in the last 15 minutes with goals from Anis Hadj Moussa, Sergio Gimenez and David Hancko, two of them after Josko Gvardiol errors. FULL-TIME | A point apiece. 🩵 3-3 ⚫️ | — Manchester City (@ManCity) Arsenal delivered the statement Champions League win Mikel Arteta had demanded as they swept aside Sporting Lisbon 5-1. Arteta wanted his team to prove their European credentials, and goals from Gabriel Martinelli, Kai Havertz, Gabriel, Bukayo Saka and Leandro Trossard got their continental campaign back on track in style following the 1-0 defeat at Inter Milan last time out. A memorable victory also ended Sporting’s unbeaten start to the season, a streak of 17 wins and one draw, the vast majority of which prompted Manchester United to prise away head coach Ruben Amorim. Putting on a show at Sporting 🌟 — Arsenal (@Arsenal) Paris St Germain were left in serious of danger of failing to progress in the Champions League as they fell to a 1-0 defeat to Bayern Munich at the Allianz Arena. Kim Min-jae’s header late in the first half was enough to send PSG to a third defeat in the competition this season, leaving them six points off the automatic qualification places for the last 16 with three games to play. Luis Enrique’s side, who had Ousmane Dembele sent off, were deservedly beaten by Bayern who dominated chances and possession. 🔔 FULL TIME – Victory at home! +3 in the 👏❤️ | — FC Bayern (@FCBayernEN) Elsewhere, Atletico Madrid were 6-0 winners away to Sparta Prague, Julian Alvarez and Angel Correa each scoring twice whilst there were also goals from Marcos Llorente and Antoine Griezmann. Barcelona ended tournament debutants Brest’s unbeaten start with a 3-0 victory courtesy of two goals from Robert Lewandowski – one a penalty – and Dani Olmo. Lewandowski’s first was his 100th Champions League goal, only the third man to reach the mark after Cristiano Ronaldo and Lionel Messi. A Castello Lukeba own goal saw Inter Milan go top of the standings with a narrow 1-0 win over RB Leipzig at San Siro, whilst Bayer Leverkusen were emphatic victors against Red Bull Salzburg, Florian Wirtz scoring twice to move Xabi Alonso’s side into the automatic qualification places. Atalanta continued their strong start, albeit whilst conceding a first goal in Europe this season in a 6-1 win away to Young Boys, whilst Tammy Abraham scored the decisive goal as AC Milan beat Slovan Bratislava 3-2.MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited TLX TLX Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx (Zircaix® 1 , 89 Zr- girentuximab) kidney cancer imaging 2 . TLX250-CDx is an investigational PET 3 drug product for the non-invasive diagnosis and characterization of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer. If approved, TLX250-CDx will be the first and only targeted PET agent specifically for kidney cancer to be commercially available in the U.S., further building on Telix's successful urology imaging franchise. The FDA is expected to advise the PDUFA 4 goal date following the 60-day administrative review of the application. Kevin Richardson, Chief Executive Officer, Precision Medicine at Telix, stated, "We are pleased to be progressing the BLA for TLX250-CDx, which has been granted Breakthrough designation, and may therefore be eligible for priority review. Telix continues to target a full U.S. commercial launch in 2025 addressing a major unmet medical need for patients with suspected ccRCC." About TLX250-CDx TLX250-CDx (Zircaix® 1 ) is an investigational PET agent that is under development for the diagnosis and characterization of ccRCC. Telix's pivotal Phase III ZIRCON trial (ClinicalTrials.gov ID: NCT03849118 ) evaluating TLX250-CDx in 300 patients, of whom 284 were evaluable, met all primary and secondary endpoints, including showing 86% sensitivity and 87% specificity and a 93% positive-predictive value for ccRCC across three independent radiology readers 5 . Telix believes this demonstrated the ability of TLX250-CDx to reliably detect the clear cell phenotype and provide an accurate, non-invasive method for diagnosing and characterizing ccRCC. Confidence intervals exceeded expectations amongst all three readers, showing evidence of high accuracy and consistency of interpretation. About Telix Pharmaceuticals Limited Telix is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange TLX and the Nasdaq Global Select Market TLX . Telix's lead imaging product, gallium-68 ( 68 Ga) gozetotide injection (also known as 68 Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA) 6 , by the Australian Therapeutic Goods Administration (TGA) 7 , and by Health Canada 8 . No other Telix product has received a marketing authorization in any jurisdiction. Visit www.telixpharma.com for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on X and LinkedIn . Telix Investor Relations Ms. Kyahn Williamson Telix Pharmaceuticals Limited SVP Investor Relations and Corporate Communications Email: kyahn.williamson@telixpharma.com This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board. Legal Notices You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website. The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement. This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as "may", "expect", "intend", "plan", "estimate", "anticipate", "believe", "outlook", "forecast" and "guidance", or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix's good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix's business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix's business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix's preclinical and clinical trials, and Telix's research and development programs; Telix's ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix's product candidates, manufacturing activities and product marketing activities; Telix's sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix's product candidates, if or when they have been approved; Telix's ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix's expenses, future revenues and capital requirements; Telix's financial performance; developments relating to Telix's competitors and industry; and the pricing and reimbursement of Telix's product candidates, if and after they have been approved. Telix's actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. ©2024 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Illuccix® and Zircaix® 1 names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. 1 Brand name subject to final regulatory approval. 2 Telix ASX disclosure 31 July 2024. The FDA requested additional data demonstrating adequate sterility assurance during dispensing of TLX250-CDx in the radiopharmacy production environment. 3 Positron emission tomography. 4 Prescription Drug User Fee Act. 5 Shuch et al. Lancet Oncol. 2024. Telix ASX disclosures 7 November 2022. 6 Telix ASX disclosure 20 December 2021. 7 Telix ASX disclosure 2 November 2021. 8 Telix ASX disclosure 14 October 2022. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.The Corruption And Incompetence Of Chicago's Mayor Knows No Bounds
French Prime Minister Michel Barnier said the country faces a “storm” in financial markets if an “unlikely but possible” alliance of lawmakers across the political spectrum rejects his government’s budget proposals and votes it out of power. The premier’s political survival hangs on whether French far-right leader Marine Le Pen’s will back a potential no-confidence vote when he presents final versions of the 2025 government and social-security budget bills in coming days and weeks. “There will probably be a rather serious storm and serious turbulences in financial markets” in case of a no-confidence vote, Barnier said in an interview with French TV channel TF1. “If the government falls, emergency measures will be taken,” which won’t cover the full year. Barnier went on TV after his boss, President Emmanuel Macron, reportedly said he believed that Le Pen would carry out her threats, and that Barnier would be out soon. Macron’s office denied he made such comments. The French prime minister also said he’ll probably have to use a constitutional provision known as 49.3 to bypass a parliamentary vote and adopt next year’s budget as his government lacks a majority in the lower house. But using the tool could lead to a no-confidence vote, which would need the backing of both the far right and the left-wing alliance New Popular Front to go through. Both groups have criticized Barnier’s budget proposals. Barnier repeated his aim to lower the budget deficit to about 5% of GDP next year, compared with 6.2% expected in 2024, through €60 billion in cuts and additional taxes. On Tuesday, the European Commission called his plan “realistic and credible.” This article was generated from an automated news agency feed without modifications to text.The expanded Big Ten is poised to be a major player in this season's College Football Playoff. The 18-team conference had three of the top-four teams in the AP poll this week — No. 1 Oregon, No. 2 Ohio State and No. 4 Penn State. A one-loss Indiana team is ranked 10th but is still very much a contender to make the playoff, given how many Southeastern Conference teams have three defeats or more. Indiana's rise has been perhaps the Big Ten's biggest story this season. Much of the spotlight was on newcomers Oregon, Southern California, UCLA and Washington, but aside from the top-ranked Ducks, that foursome has struggled to impress. Meanwhile, the Hoosiers won their first 10 games under new coach Curt Cignetti before losing at Ohio State last weekend. Oregon beat Ohio State 32-31 back in October, and if the Buckeyes beat rival Michigan this weekend, they'll earn a rematch with the Ducks for the Big Ten title. And it's entirely possible another matchup between those two teams awaits in the CFP. Dillon Gabriel has quarterbacked Oregon to an unbeaten record, throwing for 3,066 yards and 22 touchdowns in 11 games. But don't overlook Iowa's Kaleb Johnson and his 21 rushing TDs, and quarterback Kurtis Rourke has been a big part of Indiana's improvement. Penn State's Abdul Carter has eight sacks and two forced fumbles and could be one of the top edge rushers drafted this year. Oregon (11-0, 8-0), Ohio State (10-1, 7-1), Penn State (10-1, 7-1), Indiana (10-1, 7-1), Illinois (8-3, 5-3), Iowa (7-4, 5-3), Michigan (6-5, 4-4), Minnesota (6-5, 4-4), Washington (6-5, 4-4), Southern California (6-5, 4-5), Nebraska (6-5, 3-5) and Rutgers (6-5, 3-5) have already reached the six-win mark for bowl eligibility. Michigan State (5-6, 3-5) and Wisconsin (5-6, 3-5) can join them. There may not be many firings in general at the top level of college football. The prospect of sharing revenue with athletes in the future might lead schools to be more judicious about shedding one coach and hiring a new one. Who should be most worried in the Big Ten? Well, Lincoln Riley is struggling to stay above .500 in his third season at USC. Purdue is 1-10, but coach Ryan Walters is only in his second season. Maryland's Mike Locksley has been there six years and his Terrapins are 4-7, but this was his first real step backward after guiding the team to three straight bowl wins. Cignetti has shown it is possible for a coaching change to push a previously moribund program to some impressive heights in a short amount of time — but the improvement has been more incremental at Michigan State following Jonathan Smith's arrival. Sherrone Moore wasn't a completely unknown commodity at Michigan after he won some massive games in place of a suspended Jim Harbaugh last year. But in his first season completely at the helm, the Wolverines have declined significantly following their national title a season ago. The Big Ten is home to one of the most dynamic freshmen in the country in Ohio State receiver Jeremiah Smith. He has 52 catches for 899 yards and nine touchdowns. Highly touted quarterback Dylan Raiola has teamed up with fellow freshman Jacory Barney (49 catches) to lead Nebraska to bowl eligibility. Ohio State is on track to land the Big Ten's top class, according to 247 Sports, but the big news recently was quarterback Bryce Underwood flipping from LSU to Michigan. If the Wolverines do in fact keep Underwood in his home state, that would be a big development for Moore. Get local news delivered to your inbox!Throughout the last three months, 39 analysts have evaluated Nike NKE , offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 11 7 21 0 0 Last 30D 0 1 0 0 0 1M Ago 6 4 9 0 0 2M Ago 1 0 2 0 0 3M Ago 4 2 10 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $85.72, a high estimate of $110.00, and a low estimate of $70.00. Experiencing a 2.77% decline, the current average is now lower than the previous average price target of $88.16. Deciphering Analyst Ratings: An In-Depth Analysis The perception of Nike by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jonathan Komp Baird Lowers Outperform $105.00 $110.00 Jim Duffy Stifel Lowers Hold $75.00 $79.00 Joseph Civello Truist Securities Lowers Buy $90.00 $97.00 Jay Sole UBS Lowers Neutral $73.00 $80.00 Adrienne Yih Barclays Lowers Equal-Weight $70.00 $79.00 Ike Boruchow Wells Fargo Lowers Overweight $90.00 $92.00 Alex Straton Morgan Stanley Lowers Equal-Weight $74.00 $80.00 Krisztina Katai Deutsche Bank Raises Buy $84.00 $82.00 Lorraine Hutchinson B of A Securities Lowers Buy $90.00 $95.00 Tom Nikic Needham Maintains Buy $84.00 $84.00 Cristina Fernandez Telsey Advisory Group Lowers Market Perform $80.00 $93.00 Ike Boruchow Wells Fargo Lowers Overweight $92.00 $95.00 Michael Binetti Evercore ISI Group Lowers Outperform $97.00 $105.00 Krisztina Katai Deutsche Bank Lowers Buy $82.00 $92.00 Cristina Fernandez Telsey Advisory Group Lowers Outperform $93.00 $96.00 Alex Straton Morgan Stanley Lowers Equal-Weight $80.00 $82.00 Adrienne Yih Barclays Lowers Equal-Weight $79.00 $81.00 Jay Sole UBS Lowers Neutral $80.00 $82.00 Lorraine Hutchinson B of A Securities Lowers Buy $95.00 $100.00 Matthew Boss JP Morgan Lowers Neutral $73.00 $77.00 Tom Nikic Needham Announces Buy $84.00 - John Kernan TD Cowen Lowers Hold $73.00 $78.00 Piral Dadhania RBC Capital Lowers Sector Perform $80.00 $82.00 Joseph Civello Truist Securities Raises Buy $97.00 $83.00 Adrienne Yih Barclays Lowers Equal-Weight $81.00 $84.00 John Kernan TD Cowen Raises Hold $78.00 $71.00 Robert Drbul Guggenheim Lowers Buy $110.00 $115.00 Krisztina Katai Deutsche Bank Lowers Buy $92.00 $95.00 Matthew Boss JP Morgan Lowers Neutral $77.00 $80.00 Cristina Fernandez Telsey Advisory Group Lowers Outperform $96.00 $100.00 Piral Dadhania RBC Capital Lowers Sector Perform $82.00 $85.00 Michael Binetti Evercore ISI Group Lowers Outperform $105.00 $110.00 Jay Sole UBS Raises Neutral $82.00 $78.00 Joseph Civello Truist Securities Lowers Hold $83.00 $85.00 Lorraine Hutchinson B of A Securities Lowers Buy $100.00 $104.00 Randal Konik Jefferies Raises Hold $85.00 $80.00 Joseph Civello Truist Securities Maintains Hold $85.00 $85.00 Alex Straton Morgan Stanley Raises Equal-Weight $82.00 $79.00 Piral Dadhania RBC Capital Raises Sector Perform $85.00 $75.00 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Nike. This offers insight into analysts' perspectives on the current state of the company. Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Nike compared to the broader market. Price Targets: Understanding forecasts, analysts offer estimates for Nike's future value. Examining the current and prior targets provides insight into analysts' changing expectations. Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Nike's market standing. Stay informed and make well-considered decisions with our Ratings Table. Stay up to date on Nike analyst ratings. All You Need to Know About Nike Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon. Nike's Economic Impact: An Analysis Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position. Revenue Growth: Over the 3 months period, Nike showcased positive performance, achieving a revenue growth rate of 6.6% as of 30 November, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector. Net Margin: Nike's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.41% net margin, the company effectively manages costs and achieves strong profitability. Return on Equity (ROE): Nike's ROE excels beyond industry benchmarks, reaching 8.31% . This signifies robust financial management and efficient use of shareholder equity capital. Return on Assets (ROA): Nike's ROA stands out, surpassing industry averages. With an impressive ROA of 3.07% , the company demonstrates effective utilization of assets and strong financial performance. Debt Management: With a high debt-to-equity ratio of 0.86 , Nike faces challenges in effectively managing its debt levels, indicating potential financial strain. Analyst Ratings: What Are They? Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter. Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error. Which Stocks Are Analysts Recommending Now? Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market . This article was generated by Benzinga's automated content engine and reviewed by an editor. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Tasmania’s $1 billion salmon industry will supply thousands of Australian households this Christmas, its fresh and smoked fish fillets a relatively cheap alternative to many seafood options. But what is the environmental cost? Salmon farming in Tasmania. Credit: Adam Gibson Tasmania’s big three salmon producers – foreign-owned companies Huon, Tassal and Petuna – promote the industry as sustainable, with low environmental impacts. But the industry’s critics warn it is poorly regulated, environmentally harmful and expanding at an unsustainable pace. Seafood shoppers face a difficult task in deciding who to trust, especially with political leaders gearing up for an election stoush over the future of the industry. Fishy issues Salmon farms have been blamed for environmental degradation around the Tasmanian coastline, antibiotics leaking into the food chain, algal blooms, dead seals and introduction of hundreds of thousands of escapee fish into the environment. However, Salmon Tasmania chief executive Luke Martin, who heads the peak body for the industry, said the farms were a good fit for the Tasmanian environment. “We know millions of Australians will have salmon on the menu this Christmas lunch, and by doing so, they are supporting the livelihoods of 5000 Australians living across regional Tasmanian communities,” Martin said. “Salmon is also a responsibly sourced seafood farmed under the highest environmental regulatory conditions of any farmed protein in Australia. “Aquaculture also eases demand pressure on our wild fishing stocks.” A salmon farm in Tasmania. Credit: Getty Images/iStockphoto Salmon Tasmania’s website states the regulations strike a balance between growing a vital protein source, which is produced with minimal environmental impacts due to careful management. The industry states its physical footprint on the water is 4000 hectares, compared to 426 million for agriculture on land. “Tasmanian waterways are not, and never can be, overrun by salmon pens,” it said. Green gripes However, environmental groups paint a different picture. “The industry puts into the sea more pollutants than all of Tasmania’s sewage outfalls combined,” said Australian Marine Conservation Society sustainable seafood program manager Adrian Meder. The organisation’s GoodFish sustainable seafood guide told shoppers to reject Tasmanian farmed salmon this Christmas, warning that the huge expansion of the industry’s footprint “could lead to high environmental impacts”. Wild fish kilometres from salmon farms have been found with antibiotic residue in their flesh. There are strict health guidelines around food containing antibiotics, due to the potential for uncontrolled use to lead to the creation of so-called superbugs in the human population. Farmed salmon are sometimes treated with antibiotics to prevent infections that can kill fish or hurt production levels. The Salmon Tasmania website said only its veterinarians can prescribe antibiotics. Meder said nutrient-rich salmon waste is churned out from salmon pens, disrupting the marine ecosystem. It has been linked to algal blooms that have, in some instances, clogged inshore reefs in several locations near farms. A Tasmanian parliamentary inquiry completed in 2022 warned that the industry’s rapid growth had been facilitated by the state government, which is “an enthusiastic promoter and supporter of the industry”. It included several scientific expert submissions that warned about algal outbreaks and issued a recommendation for “ceasing operations in sensitive, sheltered and biodiverse areas” – a call Meder said had been ignored. Salmon Tasmania rejected these claims. “We do not know who the Australian Marine Conservation Society is, what their agenda is, or who funds them, but we are very confident in the sustainability of our operations across Tasmania,” Martin said. Harbouring doubts Macquarie Harbour on Tasmania’s west coast is not the main source of salmon supply, producing around 13 per cent of annual production. But it is where the most controversial leases are, because it is the only home for the incredibly rare and ancient relic, the Maugean skate, of which there are only 40 to 120 adults left in the wild. Salmon farming began there in the late 1980s, and all three of Tasmania’s salmon companies, Tassal, Huon and Petuna, operate in the waterway. They have recently scaled back the size of their operations as concerns about the industry’s impact on the critically endangered fish grew. The federal government’s threatened species committee said in August the best way to save the endangered fish was to eliminate, or at least dramatically cut back on, salmon farming in its habitat. The committee said there was a “significant correlation” between low oxygen levels and an increase in salmon farming. Farmed fish suck up a lot of the oxygen in the water, while fish food and faeces that enter the water via the salmon pens feed oxygen-consuming bacteria. Salmon farmers are trialling mechanical systems that push micro bubbles of oxygen to the bottom of the harbour. “No fish farming should ever pose an extinction threat to an endangered species, and no other fish farming industry in Australia does,” Meder said. “It’s actually really easy to do fish farming better than this.” Salmon Tasmania has warned that scaling back the industry could cut the 260 local jobs that it generates and claimed that multiple factors affected water quality, not just farming, including climate change and disruption from hydroelectric dams to river flows into Macquarie Harbour. Political fallout Federal Environment Minister Tanya Plibersek has on her desk a request from environment groups to revoke licences for farming in Macquarie Harbour, but a decision is not expected before an election due by May. Opposition Leader Peter Dutton has accused the government of seeking to shut down the salmon industry. “The government’s prepared to hang the local community out to dry,” he said this month. Macquarie Harbour is in the Braddon electorate, which the Liberal Party won from Labor at the 2019 election. Prime Minister Anthony Albanese has hopes to win Braddon back. He visited on December 14 and declared he would not pre-empt Plibersek’s legal responsibilities as environment minister, but nevertheless guaranteed the industry would continue under his leadership. Prime Minister Anthony Albanese visits salmon farms in Macquarie Harbour, on Tasmania’s west coast. “As long as I’m prime minister, there will be support for jobs here in Tasmania because I understand how important it is for the Tasmanian economy,” Albanese declared. Plibersek was absent from his visit. However, Plibersek said on December 19 that she welcomed the prime minister’s presence in Tasmania and echoed his support for the industry. But it was far harder to interpret her position on the future of the industry, which she said must be weighed against environmental concerns. “We know that the salmon industry is important for local jobs in Tasmania, but we also know that Tasmanians really value their natural environment ... I’m not going to comment on any decision that is before me at the moment.” Cut through the noise of federal politics with news, views and expert analysis. Subscribers can sign up to our weekly Inside Politics newsletter .
The Chinese Foreign Ministry warned the incoming administration of President-elect Donald Trump to avoid taking the Communist Party’s “goodwill for granted” and suggested “no one will win a trade war” after Trump announced a plan to impose a ten-percent tariff on Chinese goods on Monday. Trump made the tariff promise in remarks published to his social media site, Truth Social, in the context of the ongoing fentanyl crisis in the United States. He further suggested imposing tariffs on Canada and Mexico for not doing enough to curb drug production and trafficking. “Representatives of China told me that they would institute their maximum penalty, that of death, for any drug dealers caught doing this but, unfortunately, they never followed through,” Trump wrote , “and drugs are pouring into our Country, mostly through Mexico, at levels never seen before.” WATCH — “Here I Am!” — Trump Warns China over Taking Advantage of American Workers While He Was Gone: “ Until such time as they stop, we will be charging China an additional 10% Tariff, above any additional Tariffs, on all of their many products coming into the United States of America,” he asserted. Trump had previously promised a separate 60-percent tariff on Chinese goods if elected president during the 2024 campaign. Regarding North America specifically, Trump vowed that, on Inauguration Day, he will sign an executive order “to charge Mexico and Canada a 25% Tariff on ALL products coming into the United States, and its ridiculous Open Borders.” “This Tariff will remain in effect until such time as Drugs, in particular Fentanyl, and all Illegal Aliens stop this Invasion of our Country!” he continued. “Both Mexico and Canada have the absolute right and power to easily solve this long simmering problem. We hereby demand that they use this power, and until such time that they do, it is time for them to pay a very big price!” Migrants walk along the Huixtla highway after departing Tapachula, southern Mexico, hoping to reach the country’s northern border and ultimately the United States, on November 5, 2024. (AP Photo/Moises Castillo) The Chinese Foreign Ministry initially did not respond to the comments during its regular press briefing Tuesday. A spokesman later issued a statement discouraging Trump from adopting the policies. “China on Tuesday urged the US not to take China’s goodwill for granted and work to ensure that the hard-won positive dynamics will stay in the China-US counternarcotics cooperation,” the Chinese state propaganda newspaper Global Times reported, paraphrasing the Foreign Ministry. “About the issue of US tariffs on China, China believes that China-US economic and trade cooperation is mutually beneficial in nature. No one will win a trade war or a tariff war,” the Foreign Ministry spokesman was quoted as saying in a statement to the Global Times. The spokesman went on to claim that China had “carried out extensive and in-depth counternarcotics cooperation with the US” despite being the source of many of the precursor chemicals later used in the production of fentanyl. In February, the U.S. Centers for Disease Control (CDC) reported that it was documenting over 150 deaths a day in America as a result of synthetic opioids, driven in large part by the growing prevalence of fentanyl in the country. Many of those deaths involved the inadvertent consumption of fentanyl, mixed into other drugs in fatal quantities. China plays a major role in the production of fentanyl through cooperation with Mexican drug cartels to produce fentanyl in North America. The Chinese government vehemently denies any role in the fentanyl crisis, blaming inferior American “ culture ” for the issue. WATCH — Fmr. Trump Official: Biden’s Border Rules Let Chinese Fentanyl into U.S.: Separately, at an event promoting more Chinese dominance of global supply chains, Chinese Vice President Han Zheng lamented what he called the “fragmentation of the world economy” and a “new period of turmoil and change,” presumably looming in the expectation that Trump will be inaugurated into the presidency in January. Han encouraged an audience of business leaders, including representatives of the American tech company Apple, to “build consensus and strengthen links to contribute to maintaining the stability of the global supply chains,” according to the South China Morning Post . Chinese Premier Li Qiang similarly addressed the venue, the “China International Supply Chain Expo,” “opposing all forms of decoupling and firmly upholding stable and unimpeded global industrial and supply chains.” “China is a key link in global industrial and supply chains and will continue to take concrete actions to maintain the stability and smooth operation of these chains,” Li promised , according to the state-run China Daily . “Exclusiveness leads nowhere, while openness is the right path forward,” Li warned, adding that “protectionist moves and overstretching of security are harming global industrial and supply chains,” without naming Trump specifically. Li also recruited international corporations to “be steadfast defenders” of China’s dominance of supply chains and “continue firmly supporting economic globalization.” This photo released by the Casa Grande Police Department, shows a collagen supplement bottle that concealed approximately 500,000 fentanyl pills that were found in an SUV pulled over for speeding on Interstate 10 in Pinal County, Arizona, on May 23, 2022. (Casa Grande Police Department via AP) Beijing has intensified its defense of economic globalization in light of Trump’s electoral victory in November. Genocidal dictator Xi Jinping himself pressured foreign countries to resist calls for economic nationalism during a tour of South America this month, making stops at the Asia Pacific Economic Cooperation (APEC) summit in Peru and the G20 summit in Brazil. In his speech to the G20, Xi demanded the parties assembled “oppose unilateralism and protectionism.” “We need to improve global financial governance and build a world economy characterized by stability,” Xi lectured , adding later, “We need to improve global trade governance and build a world economy characterized by openness.” “It is important to avoid politicizing economic issues, avoid fragmenting the global market, and avoid taking protectionist moves in the name of green and low-carbon development,” Xi he added. Follow Frances Martel on Facebook and Twitter.The National Hajj Commission of Nigeria (NAHCON) on Tuesday inaugurated a 32-man Screening/Aviation Monitoring Committee for 2025 Hajj air-carriers and cargo conveyers. Also, the commission inaugurated was a six-man secretariat for the Committee. NAHCON’s Assistant Director, Public Affairs, Fatima Sanda Usara, in a statement she signed on behalf of the commission chairman informed that the inauguration, held at the Hajj House headquarters of the Hajj body, was followed by opening of application forms for the issuance of Hajj licence for airlift of the 2025 pilgrims from Nigeria. According to her, “This sets the pace for series of activities that will culminate in the selection of pilgrims’ air carriers as well as excess luggage freighters for the 2025 Hajj exercise.” She stated that the 32-man Committee, chaired by NAHCON’s Commissioner of Operations, Inspection and Licensing (OILS), Prince Anofi Olanrewaju Elegushi, drew membership from several aviation industry managers as well as stakeholders from the State Pilgrims’ Welfare Boards, representative from the Presidency, security agencies and NAHCON staff. “The composition of the Committees include five representatives from State Pilgrims’ Welfare Boards, three from Nigerian Civil Aviation Authority (NCAA) and one member each from Federal Airports Authority of Nigeria (FAAN), Nigerian Airspace Management Agency (NAMA), Nigerian Meteorological Agency (NIMET) and Nigerian Safety Investigation Bureau (NSIB). “Similarly, one member each was drawn from Nigerian Customs’ Service (NCS) and Independent Corrupt Practices Commission (ICPC). Others are NAHCON Board members representing each geo-political zone of the country, NAHCON Heads of Aviation, Procurement, Legal, Internal Audit, Special Duties as well as Board Member representing the Aviation industry,” Usara stated. She added that 11 airlines, including two from Saudi Arabia, sent applications indicating interest in the airlift of pilgrims for next year’s Hajj. Under the airlift bilateral agreement, the two airlines from the Kingdom of Saudi Arabia are FlyNas and Flyadeal. The nine applications are from Nigerian airline companies are: Air Peace; GYRO Air Limited; Max Air Ltd; Nahco Aviance; Tarco Aviation; Umra Airline Limited standing for Ethiopian Airlines; UMZA Aviation Services Limited; Value Jet and Trebet Aviation Ltd. Usara further stated that five cargo companies applied for excess luggage transportation. They are Aglow Aviation Support Services Limited; Cargo Zeal Technologies; Qualla Investment; Kiswah Logistics Services Limited and Sokodeke Global Travels and Cargo. The term of reference of the airline screening committee, according to Usara, included, among others, to: Screen the prospective carriers that applied for license for the airlift of pilgrims and those for excess luggage in respect of the 2025 Hajj; decline the screening of any applicant whose status or documents are at variance with the conditions of application as stated in the adverts, and application form. The Committee is expected to submit its report by Monday, December 2. NIGERIAN TRIBUNE Get real-time news updates from Tribune Online! Follow us on WhatsApp for breaking news, exclusive stories and interviews, and much more. Join our WhatsApp Channel now
It looked like a recipe for disaster. So, when his country's swimmers were being accused of doping earlier this year, one Chinese official cooked up something fast. He blamed it on contaminated noodles. In fact, he argued, it could have been a culinary conspiracy concocted by criminals, whose actions led to the cooking wine used to prepare the noodles being laced with a banned heart drug that found its way into an athlete's system. This theory was spelled out to international anti-doping officials during a meeting and, after weeks of wrangling, finally made it into the thousands of pages of data handed over to the lawyer who investigated the case involving 23 Chinese swimmers who had tested positive for that same drug. The attorney, appointed by the World Anti-Doping Agency, refused to consider that scenario as he sifted through the evidence. In spelling out his reasoning, lawyer Eric Cottier paid heed to the half-baked nature of the theory. “The Investigator considers this scenario, which he has described in the conditional tense, to be possible, no less, no more,” Cottier wrote. Even without the contaminated-noodles theory, Cottier found problems with the way WADA and the Chinese handled the case but ultimately determined WADA had acted reasonably in not appealing China's conclusion that its athletes had been inadvertently contaminated. Critics of the way the China case was handled can't help but wonder if a wider exploration of the noodle theory, details of which were discovered by The Associated Press via notes and emails from after the meeting where it was delivered, might have lent a different flavor to Cottier's conclusions. “There are more story twists to the ways the Chinese explain the TMZ case than a James Bond movie,” said Rob Koehler, the director general of the advocacy group Global Athlete. "And all of it is complete fiction.” In April, reporting from the New York Times and the German broadcaster ARD revealed that the 23 Chinese swimmers had tested positive for the banned heart medication trimetazidine, also known as TMZ. China's anti-doping agency determined the athletes had been contaminated, and so, did not sanction them. WADA accepted that explanation , did not press the case further, and China was never made to deliver a public notice about the “no-fault findings,” as is often seen in similar cases. The stock explanation for the contamination was that traces of TMZ were found in the kitchen of a hotel where the swimmers were staying. In his 58-page report , Cottier relayed some suspicions about the feasibility of that chain of events — noting that WADA's chief scientist “saw no other solution than to accept it, even if he continued to have doubts about the reality of contamination as described by the Chinese authorities.” But without evidence to support pursuing the case, and with the chance of winning an appeal at almost nil, Cottier determined WADA's “decision not to appeal appears indisputably reasonable.” A mystery remained: How did those traces of TMZ get into the kitchen? Shortly after the doping positives were revealed, the Institute of National Anti-Doping Organizations held a meeting on April 30 where it heard from the leader of China's agency, Li Zhiquan. Li's presentation was mostly filled with the same talking points that have been delivered throughout the saga — that the positive tests resulted from contamination from the kitchen. But he expanded on one way the kitchen might have become contaminated, harkening to another case in China involving a low-level TMZ positive. A pharmaceutical factory, he explained, had used industrial alcohol in the distillation process for producing TMZ. The industrial alcohol laced with the drug “then entered the market through illegal channels,” he said. The alcohol "was re-used by the perpetrators to process and produce cooking wine, which is an important seasoning used locally to make beef noodles,” Li said. “The contaminated beef noodles were consumed by that athlete, resulting in an extremely low concentration of TMZ in the positive sample. "The wrongdoers involved have been brought to justice.” This new information raised eyebrows among the anti-doping leaders listening to Li's report. So much so that over the next month, several emails ensued to make sure the details about the noodles and wine made their way to WADA lawyers, who could then pass it onto Cottier. Eventually, Li did pass on the information to WADA general counsel Ross Wenzel and, just to be sure, one of the anti-doping leaders forwarded it, as well, according to the emails seen by the AP. All this came with Li's request that the noodles story be kept confidential. Turns out, it made it into Cottier's report, though he took the information with a grain of salt. “Indeed, giving it more attention would have required it to be documented, then scientifically verified and validated,” he wrote. Neither Wenzel nor officials at the Chinese anti-doping agency returned messages from AP asking about the noodles conspiracy and the other athlete who Li suggested had been contaminated by them. Meanwhile, 11 of the swimmers who originally tested positive competed at the Paris Games earlier this year in a meet held under the cloud of the Chinese doping case. Though WADA considers the case closed, Koehler and others point to situations like this as one of many reasons that an investigation by someone other than Cottier, who was hired by WADA, is still needed. “It gives the appearance that people are just making things up as they go along on this, and hoping the story just goes away," Koehler said. “Which clearly it has not.” AP Olympics: https://apnews.com/hub/2024-paris-olympic-gamesEd Sheeran, Sir Bob Geldof and the Band Aid controversy — everything we know so far
USD women down Dayton in first game of Music City Classic
Constitution is a guide to our present and future, says ModiVeteran forward Bruce Brown’s return a boost to flagging Toronto Raptors’ lineup
After institutions for people with disabilities close, graves are at risk of being forgottenBig Ten could place four teams in playoff, thanks to IU's rise
Ireland blamed Northern Ireland Office for ‘damaging leaks’, records showTimeline: Jimmy Carter, 1924-2024SAST TV announced, ushering a new era in theatre